<DOC>
	<DOC>NCT00563862</DOC>
	<brief_summary>To test the therapeutic ratio of accelerated radiotherapy and/or chemotherapy on locally advanced nasopharyngeal carcinoma.</brief_summary>
	<brief_title>Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0)</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Carcinoma, Squamous Cell</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Undifferentiated or nonkeratinizing carcinoma Tumor staged as T34 AND N01 No evidence of distant metastasis (M0) Performance status: 02 Marrow: WBC &gt;= 4 and platelet = 100 Renal: creatinine clearance = 60 Informed consent WHO type I squamous cell carcinoma or adenocarcinoma Age &gt;= 70 Palliative intent or tumor extent mandating AP opposing faciocervical fields Prior malignancy except adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, or other cancer for which the patient has been diseasefree for 5 years Previous radiotherapy (except nonmelanomatous skin cancers outside the intended RT treatment volume Previous chemotherapy Patient is pregnant or lactating</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Nasopharyngeal Carcinoma</keyword>
	<keyword>T3-4N0-1M0</keyword>
</DOC>